Vincent Medical Holdings Limited AI Stock Analysis
Want to see HK:1612 full AI Analyst Report?
Vincent Medical Holdings Limited (1612) AI Stock Analysis
Vincent Medical Holdings Limited
(HKEX:1612)
The stock earns a moderately strong score driven primarily by a solid financial profile, with profitability and margins rebounding and a conservative balance sheet, while an undemanding valuation with a low P/E and high dividend yield further supports the rating. These positives are tempered by a history of cyclical revenue and earnings and uneven free cash flow, alongside neutral-to-soft technicals that show limited current price momentum, keeping the score below the top tier.
Vincent Medical Holdings Limited (1612) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 451.82M
- Dividend Yield
- 6.62%
- Average Volume (3M)
- 165.50K
- Price to Earnings (P/E)
- 4.7
- Beta (1Y)
- 0.78
- Revenue Growth
- 10.95%
- EPS Growth
- 9.26%
- Country
- Hong Kong
- Employees
- 1,556
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Vincent Medical Holdings Limited Business Overview & Revenue Model
Company Description
Vincent Medical Holdings Limited is an investment holding company engaged in the comprehensive process of designing, manufacturing, marketing, and distributing medical devices. Its operations are bifurcated into two main business models: providing pr...
Vincent Medical Holdings Limited Financial Statement Overview
Summary
Score reflects recovered profitability with low double-digit margins, a conservatively financed balance sheet with growing equity and moderate debt, offset by cyclical revenue and earnings and volatile free cash flow that weakens cash conversion.
Income Statement
72PositiveBalance Sheet
80PositiveCash Flow
58Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 964.90M | 932.78M | 800.96M | 717.97M | 629.24M | 777.72M |
| Gross Profit | 333.74M | 327.44M | 259.99M | 240.39M | 147.83M | 243.83M |
| EBITDA | 164.90M | 170.76M | 114.39M | 104.11M | 29.95M | 114.55M |
| Net Income | 96.30M | 104.38M | 69.17M | 57.27M | -17.40M | 60.70M |
Balance Sheet | ||||||
| Total Assets | 1.27B | 1.17B | 919.68M | 786.61M | 726.70M | 846.15M |
| Cash, Cash Equivalents and Short-Term Investments | 199.93M | 250.87M | 173.44M | 175.78M | 159.34M | 173.17M |
| Total Debt | 240.66M | 177.42M | 99.65M | 37.38M | 60.39M | 62.96M |
| Total Liabilities | 546.08M | 498.33M | 336.33M | 243.52M | 228.09M | 245.72M |
| Stockholders Equity | 715.77M | 664.65M | 578.55M | 541.84M | 498.01M | 598.36M |
Cash Flow | ||||||
| Free Cash Flow | -25.52M | 54.64M | -26.52M | 61.28M | 57.67M | 94.48M |
| Operating Cash Flow | 59.99M | 168.42M | 73.48M | 124.97M | 76.27M | 119.43M |
| Investing Cash Flow | -86.77M | -119.77M | -98.81M | -62.37M | -18.61M | -20.69M |
| Financing Cash Flow | 20.84M | 27.34M | 26.39M | -45.37M | -67.84M | -101.16M |
Vincent Medical Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1612, the sentiment is Positive. The current price of 0.69 is below the 20-day moving average (MA) of 0.70, above the 50-day MA of 0.69, and below the 200-day MA of 0.78, indicating a neutral trend. The MACD of -0.00 indicates Positive momentum. The RSI at 52.74 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1612.
Vincent Medical Holdings Limited Peers Comparison
Overall Rating
HK:178977Outperform
HK:185872Outperform
HK:161271.1Outperform
HK:217265Neutral
HK:666951Neutral
HK:999645Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | HKD 5.24B | 11.80 | 13.24% | 2.50% | 16.15% | 31.89% | |
| 72Outperform | HKD 5.07B | 18.46 | 8.83% | 5.59% | -9.00% | 10.62% | |
| 71Outperform | HKD 458.77M | 4.67 | 13.95% | 6.62% | 10.95% | 9.26% | |
| 65Neutral | HKD 4.71B | 21.32 | 10.38% | 1.74% | 3.83% | -27.04% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | HKD 1.41B | -23.85 | -3.50% | ― | 9.36% | -153.54% | |
| 45Neutral | HKD 2.47B | -14.66 | -7.65% | ― | 21.23% | 36.89% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1612 | Vincent Medical Holdings Limited | 0.69 | -0.09 | -11.01% | |
| HK:9996 | Peijia Medical Ltd. | 3.65 | -1.99 | -35.28% | |
| HK:6669 | Acotec Scientific Holdings Limited | 4.49 | -8.43 | -65.26% | |
| HK:1789 | AK Medical Holdings Ltd. | 4.72 | -0.93 | -16.50% | |
| HK:1858 | Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H | 7.20 | -10.25 | -58.75% | |
| HK:2172 | MicroPort NeuroTech Limited | 8.05 | -2.88 | -26.31% |
Vincent Medical Holdings Limited Corporate Events
Vincent Medical Grows Revenue as New China Plant Weighs on Profit
Vincent Medical Holdings reported a 7.1% year-on-year rise in revenue to HK$481.6 million for the six months ended 30 June 2026, driven mainly by a 7.2% increase in its imaging disposable products segment to HK$261.6 million. Despite higher raw mater...
Vincent Medical Declares Interim HKD0.02 Dividend for First Half of 2026
Vincent Medical Holdings Limited has announced an interim ordinary cash dividend of HKD 0.02 per share for the six months ended 30 June 2026, for the financial year ending 31 December 2026. The dividend reflects the board’s decision to return cash to...
Vincent Medical strengthens board with new independent director
Vincent Medical Holdings Limited has appointed Ms. Liu Yin Yan Elizabeth as an independent non-executive director, effective 26 August 2026, strengthening its board with extensive Hong Kong legal and capital markets experience. Liu, a qualified solic...
Vincent Medical Clarifies Board and Committee Structure Effective August 2026
Vincent Medical Holdings Limited has updated its board composition, confirming a mix of executive, non-executive and independent non-executive directors effective 26 August 2026. The chairman role is held by Mr. Choi Man Shing, while Mr. Choi Cheung...
Vincent Medical Sets August Board Meeting to Approve Interim Results and Dividend
Vincent Medical Holdings Limited has scheduled a board meeting for 25 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider the publication of these interim results and evaluate the...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
